What is the appropriate prophylactic aspirin dose for a non‑surgical, non‑displaced patellar fracture?

Aspirin Prophylaxis for Non-Surgical, Non-Displaced Patellar Fracture

For a non-surgical, non-displaced patellar fracture, routine thromboprophylaxis with aspirin is not recommended. 1

Rationale

The ACCP guidelines explicitly advise against routine prophylaxis for isolated lower extremity injuries treated without operation (Grade 1A recommendation) 1. This applies directly to your scenario of a non-displaced patellar fracture managed conservatively. The guidelines state it is uncertain whether thromboprophylaxis reduces clinically significant DVT in these cases or whether it is cost-effective.

Key Decision Points

When NOT to give aspirin prophylaxis:

• Isolated lower extremity injury
• No surgical intervention
• No additional VTE risk factors present
• Ambulatory or minimally immobilized patient

When TO CONSIDER aspirin prophylaxis:

• Presence of additional risk factors (history of VTE, cancer, prolonged immobilization, obesity, advanced age)
• Extended cast immobilization expected
• Multiple injuries or polytrauma

If Prophylaxis Is Indicated

If you determine that risk factors warrant prophylaxis despite the non-operative nature, the evidence supports:

Aspirin dosing options:

• 81 mg twice daily (most commonly studied dose in recent high-quality trials) 2
• Alternative: 160 mg once daily (used in PEP trial) 3

Duration:

• Continue for the period of significant immobilization or reduced mobility
• Typically 2-4 weeks for lower extremity fractures when used 2, 4

Important Caveats

The robust evidence for aspirin in orthopedic thromboprophylaxis comes from operative fracture management and arthroplasty populations 2, 5, 6. The PREVENT CLOT trial, which demonstrated non-inferiority of aspirin to enoxaparin, specifically enrolled patients with operatively treated extremity fractures or any pelvic/acetabular fracture 2. Your patient with a non-operative patellar fracture represents a fundamentally lower-risk scenario.

The ICS guidelines recommend LMWH only if risk factors are present for non-operative lower limb injuries 1, suggesting a risk-stratified rather than routine approach.

Practical Algorithm

1. Assess VTE risk factors: Prior VTE, active cancer, age >60, obesity (BMI >30), smoking, prolonged immobilization expected
2. If NO risk factors: No prophylaxis needed
3. If 1-2 risk factors: Consider aspirin 81 mg twice daily for duration of immobilization
4. If ≥3 risk factors or prior VTE: Consider LMWH over aspirin

The evidence clearly supports withholding routine prophylaxis in your low-risk scenario, reserving aspirin for patients with identifiable risk factors that elevate their baseline VTE risk above the threshold where benefits outweigh costs and potential harms.